Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 75 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
Φίλτρα: Keyword is Disease-Free Survival  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Arzoglou, V., Tsitlakidis A., Foroglou N., Polyzoidis K., Makri S., & Patsalas I. (2018).  Does proximity to the subventricular zone and expression of CXCR-4 and nestin affect prognosis in high-grade glioma?. Br J Neurosurg. 32(6), 614-618.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2013).  Statins and nonalcoholic fatty liver disease: a bright future?. Expert Opin Investig Drugs. 22(9), 1089-93.
Athyros, V. G., Karagiannis A., Ganotakis E. S., Paletas K., Nicolaou V., Bacharoudis G., et al. (2011).  Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study.. Curr Med Res Opin. 27(8), 1659-68.
B
Bamias, A., Dafni U., Karadimou A., Timotheadou E., Aravantinos G., Psyrri A., et al. (2013).  Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).. Ann Oncol. 24(4), 1011-7.
Bourlidou, E., Vahtsevanos K., Kyrgidis A., Tilaveridis I., Patsatsi A., Andreadis D., et al. (2019).  Risk factors for local recurrence of basal cell carcinoma and cutaneous squamous cell carcinoma of the middle third of the face: a 15-year retrospective analysis based on a single centre.. Eur J Dermatol. 29(5), 490-499.
C
Carvajal-Hausdorf, D. E., Schalper K. A., Pusztai L., Psyrri A., Kalogeras K. T., Kotoula V., et al. (2015).  Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer.. J Natl Cancer Inst. 107(8), 
Christodoulou, C., Oikonomopoulos G., Koliou G. Angeliki, Kostopoulos I., Kotoula V., Bobos M., et al. (2018).  Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab.. Cancer Genomics Proteomics. 15(6), 461-471.
Cohen, S. A., Wu C., Yu M., Gourgioti G., Wirtz R., Raptou G., et al. (2016).  Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.. Clin Colorectal Cancer. 15(2), 164-9.
Crown, J. P., Diéras V., Staroslawska E., Yardley D. A., Bachelot T., Davidson N., et al. (2013).  Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.. J Clin Oncol. 31(23), 2870-8.
D
Demetetriades, H., Marakis G. N., Ziogas D., & Kanellos I. (2009).  Robotic D2 surgery for gastric cancer.. Surg Endosc. 23(8), 1919-21; author reply 1922-3.
Demetriades, H., Kanellos I., Vasiliadis K., Angelopoulos S., Vergos O., Kanellos D., et al. (2004).  Age-associated prognosis following curative resection for colorectal cancer.. Tech Coloproctol. 8 Suppl 1, s144-6.
E
Escudier, B., Roigas J., Gillessen S., Harmenberg U., Srinivas S., Mulder S. F., et al. (2009).  Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma.. J Clin Oncol. 27(25), 4068-75.
F
Fountzilas, G., Bamias A., Kalogera-Fountzila A., Karayannopoulou G., Bobos M., Athanassiou E., et al. (2009).  Induction chemotherapy with docetaxel and cisplatin followed by concomitant chemoradiotherapy in patients with inoperable non-nasopharyngeal carcinoma of the head and neck.. Anticancer Res. 29(2), 529-38.
Fountzilas, E., Kotoula V., Angouridakis N., Karasmanis I., Wirtz R. M., Eleftheraki A. G., et al. (2013).  Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer.. PLoS One. 8(8), e70429.
Fountzilas, G., Dafni U., Bobos M., Batistatou A., Kotoula V., Trihia H., et al. (2012).  Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel.. PLoS One. 7(6), e37946.
Fountzilas, G., Kotoula V., Pectasides D., Kouvatseas G., Timotheadou E., Bobos M., et al. (2013).  Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial.. PLoS One. 8(7), e69256.
Fountzilas, G., Dafni U., Papadimitriou C., Timotheadou E., Gogas H., Eleftheraki A. G., et al. (2014).  Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial.. BMC Cancer. 14, 515.
Fountzilas, G., Psyrri A., Giannoulatou E., Tikas I., Manousou K., Rontogianni D., et al. (2018).  Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.. Int J Cancer. 142(1), 66-80.
Fountzilas, G., Giannoulatou E., Alexopoulou Z., Zagouri F., Timotheadou E., Papadopoulou K., et al. (2016).  TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.. Oncotarget. 7(22), 32731-53.
G
Galimberti, V., Manika A., Maisonneuve P., Corso G., L Moltrasio S., Intra M., et al. (2014).  Long-term follow-up of 5262 breast cancer patients with negative sentinel node and no axillary dissection confirms low rate of axillary disease.. Eur J Surg Oncol. 40(10), 1203-8.
Giannopoulos, G., Kossyvakis C., Angelidis C., Panagopoulou V., Tsiachris D., Vrachatis D. A., et al. (2017).  Coincidental ganglionated plexus modification during radiofrequency pulmonary vein isolation and post-ablation arrhythmia recurrence.. Europace. 19(12), 1967-1972.
Gkritsios, P., Hatzimouratidis K., Kazantzidis S., Dimitriadis G., Ioannidis E., & Katsikas V. (2014).  Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial.. Int Urol Nephrol. 46(5), 927-33.
Gogas, H., Pectasides D., Kostopoulos I., Lianos E., Skarlos D., Papaxoinis G., et al. (2010).  Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group.. Clin Breast Cancer. 10(3), 230-7.
Gogas, H., Dafni U., Karina M., Papadimitriou C., Batistatou A., Bobos M., et al. (2012).  Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.. Breast Cancer Res Treat. 132(2), 609-19.
H
Heron, D. E., Ferris R. L., Karamouzis M., Andrade R. S., Deeb E. L., Burton S., et al. (2009).  Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial.. Int J Radiat Oncol Biol Phys. 75(5), 1493-500.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές